When the Body Turns Against Itself - Understanding and Using Adrenaline Auto-Injectors
When the Body Turns Against Itself: Understanding and Using Adrenaline Auto-Injectors
Anaphylaxis is the most dangerous expression of allergic disease — a life-threatening systemic reaction that can escalate from the first symptom to cardiovascular collapse in a matter of minutes. Adrenaline auto-injectors like EpiPen, Jext, and Emerade are the first and most critical line of defence. Yet studies have consistently found that a significant proportion of people who carry them — patients, parents, teachers, and carers alike — are uncertain about when and how to use them correctly. In a genuine emergency, that uncertainty costs time that the body cannot spare.
What Is Anaphylaxis, and Why Does It Happen So Fast?
Anaphylaxis is a severe, whole-body allergic reaction triggered when the immune system responds to a perceived threat — a food protein, an insect venom, a medicine — with a catastrophic release of chemical mediators, most notably histamine. Unlike a localised allergic reaction, which might produce hives or a runny nose, anaphylaxis floods the entire body. Blood vessels dilate dramatically, causing blood pressure to plummet. Airways narrow and can swell shut. Fluid leaks from blood vessels into surrounding tissue. The body, in short, begins to shut down.
The speed of onset is what makes anaphylaxis so dangerous. Symptoms typically appear within minutes of exposure to the trigger — sometimes within seconds. Common early signs include sudden swelling of the lips, mouth, or throat; difficulty swallowing or speaking; a feeling of tightening in the chest; rapid or laboured breathing; a blotchy, raised rash; dizziness or faintness; and a rapid, weak pulse. Nausea, vomiting, and a sense of impending doom are also frequently reported. In people with darker skin tones, the pallor or greyish colour that signals circulatory collapse may be more visible on the palms of the hands or soles of the feet.
Not every symptom needs to be present. If someone has been exposed to a known or suspected trigger and is showing any combination of the above, anaphylaxis must be assumed and treated immediately.
The First-Line Treatment: Adrenaline
Adrenaline — also known as epinephrine — is the definitive treatment for anaphylaxis. It works by narrowing the blood vessels, raising blood pressure, relaxing the muscles of the airway to ease breathing, and suppressing the release of inflammatory chemicals. Nothing else currently available acts as quickly or as comprehensively across the life-threatening features of the reaction.
It is important to understand what adrenaline is not. Antihistamines and corticosteroids — hydrocortisone, for example — have historically been used alongside adrenaline as secondary treatments, but updated guidance from NICE in recent years has removed them from the recommended first-line emergency protocol for anaphylaxis. They act too slowly to address the acute cardiovascular and respiratory emergency. Adrenaline, delivered intramuscularly into the outer thigh, reaches peak plasma concentration in around eight minutes. Antihistamines do not come close. If adrenaline is available, it goes in first. There is no step before it.
The Three Auto-Injectors Available in the UK
Three adrenaline auto-injectors are currently licensed for use in the United Kingdom: EpiPen, Jext, and Emerade. All three are disposable, single-use, pre-filled injection devices designed to deliver a precise dose of adrenaline into the outer thigh muscle. Though their purpose is identical, their design and method of use differ — and this matters more than most people appreciate.
EpiPen is the most globally recognised device. It comes in two doses: the adult version (yellow label, 0.3mg) and the junior version (white label with yellow stripe, 0.15mg). To use an EpiPen, the blue safety cap is removed from one end and the orange tip — which contains the needle — is pressed firmly against the outer thigh until a click is felt, then held in place for several seconds for the full dose to be delivered.
Jext is broadly similar in design and dosing: the adult Jext 300 delivers 0.3mg, and the Jext 150 delivers 0.15mg. It uses a yellow cap and a black tip, with the needle emerging from the black end. Its instructions have been criticised in research settings as more difficult to follow under stress than those of Emerade.
Emerade differs in a key respect: the cap is removed from the needle end of the device, making it immediately apparent where the needle exits — reducing the risk of accidental injection into the wrong end, a more common error than manufacturers would like. Emerade is also the only device available in a 500 microgram dose, intended for larger adult patients. Research has found that Emerade’s needle is longer than those of EpiPen and Jext, which may be significant: a study found that the shorter needles on EpiPen and Jext were insufficient to reach the intramuscular layer in a majority of adult patients tested, potentially delivering the drug subcutaneously rather than into the muscle — a substantially slower route of absorption.
The critical point is this: these devices are not interchangeable without training. If a patient is switched from one brand to another, they — and everyone responsible for their care — must be trained on the new device. Assuming the technique from one device applies to another is a dangerous error.
How to Use an Auto-Injector: The Principles That Apply to All Devices
While the specific steps vary by device, several core principles apply universally. Learning these builds the mental framework that makes correct action possible under the stress of a real emergency.
The outer thigh is always the target. Adrenaline must be injected into the muscle of the outer mid-thigh — the vastus lateralis — not the inner thigh, not the buttock, not the upper arm. The outer thigh is the correct site because the muscle there is large, accessible, and well-vascularised, allowing the drug to be absorbed quickly. It can be injected through clothing in most cases, though thick fabrics like denim should be avoided where possible.
Hold it in place. After the device has activated — you will typically hear or feel a click — keep it pressed firmly against the thigh for at least ten seconds. Removing it immediately after activation risks incomplete delivery of the dose.
It can be given through clothing. In an emergency, removing clothing should not delay the injection. Modern auto-injectors are designed to penetrate light clothing, though it is worth practising this awareness so that the reflex to undress does not slow things down.
A second dose may be needed. Every person who carries an auto-injector should carry two, and both should be within date. If there is no improvement within five to fifteen minutes of the first injection, or if the person initially improves and then deteriorates again, the second device should be used in the opposite thigh. The biphasic nature of some anaphylactic reactions — where symptoms return hours after the initial episode — is one of the reasons that hospital observation after every anaphylactic episode is non-negotiable, even when the person appears to have recovered.
”Orange to the Sky, Blue to the Thigh”
For EpiPen users specifically — and for anyone who might need to administer one in an emergency with no prior training — there is a mnemonic worth knowing by heart: orange to the sky, blue to the thigh. The orange tip contains the needle and goes against the leg. The blue safety cap is at the top and is removed first, pointed away from the body. This simple phrase has the potential to prevent one of the most common errors in auto-injector use: accidentally injecting into the palm of the hand by holding the device the wrong way around. Accidental hand injection is a medical emergency in its own right, as it can cause vasoconstriction severe enough to damage tissue. The mnemonic is not a substitute for training, but it is a potentially life-saving fallback for bystanders who have never used the device before.
For Jext: the yellow cap comes off first, and the black tip — which contains the needle — goes against the thigh. A helpful way to remember this: yellow cap off, black tip down.
For Emerade: the cap comes off the needle end of the device. The needle exit is clearly visible once the cap is removed, making correct orientation the most intuitive of the three devices.
What to Do After Using an Auto-Injector: The Steps That Cannot Be Skipped
Using the auto-injector is not the end of the emergency response. It is the beginning.
Call 999 immediately. Whether the injection has already been given or not, an ambulance must be called without delay. When the call connects, use the word anaphylaxis — an-a-fil-ax-is — clearly. Ambulance operators are trained to prioritise calls that include this word. Do not describe it only as “an allergic reaction” or “a bad reaction” — anaphylaxis is a specific, life-threatening emergency that requires the fastest possible response. Say it directly.
The reason calling 999 is mandatory even when the injection appears to have worked is the risk of biphasic reaction. Adrenaline is not a cure — it is a temporary bridge. Its effects last only fifteen to thirty minutes. Without further treatment in a hospital setting, symptoms can and do return.
Position matters. After the injection, the person should lie flat with their legs raised, which helps maintain blood flow to the heart and vital organs in the context of hypotension. This is not a minor detail — lying flat with raised legs is a clinically meaningful intervention in anaphylactic shock, not simply a comfort measure. If the person is struggling to breathe, they may need to sit up slightly; a compromise position with legs raised and the upper body gently propped is acceptable, and they should return to lying flat as soon as breathing permits. If the person is unconscious, place them in the recovery position: on their side, supported by one arm and one leg, with the head tilted back to maintain the airway. If the person is pregnant, they should lie on their left side.
Do not allow them to stand or walk, even if they insist they feel better. Standing up during anaphylaxis can trigger cardiovascular collapse by redirecting already insufficient blood flow away from the vital organs. Several deaths from anaphylaxis have been associated with the patient standing up too soon.
Stay with the person. Do not leave them alone while waiting for the ambulance.
Bring the used device to hospital. Used auto-injectors should be taken to the hospital and given to the ambulance crew or attending clinician for safe disposal. They also provide confirmation of the dose given and the brand used.
Looking After Your Auto-Injectors Day to Day
The moments of an anaphylactic emergency are not the time to discover that a device is out of date, damaged, or ineffective. Good day-to-day habits around auto-injectors are as important as knowing how to use them.
Always carry two. Guidance from the MHRA, NHS, and all major allergy organisations is consistent on this point: two devices should be carried at all times. A single device may fail, may deliver an incomplete dose, or may be insufficient if a second reaction occurs before the ambulance arrives.
Check the expiry date regularly. Expired devices may deliver a degraded dose of adrenaline — potentially insufficient to reverse a severe reaction. Many device manufacturers offer free expiry alert services by email or through dedicated apps, including Jext and EpiPen. These are worth registering for.
Inspect the liquid. EpiPen and Jext devices have a viewing window. The adrenaline solution should be clear and colourless. If it has turned pink or brown, or contains visible particles, the device should be replaced immediately and the old one returned to a pharmacist.
Store them correctly. Auto-injectors should be kept at room temperature. They should not be stored in the fridge, in a car glove compartment in summer, or in direct sunlight — extremes of temperature degrade the adrenaline. Many people keep one at home and carry one with them at all times; others keep one at their workplace or their child’s school, where arrangements for storage and trained administration should form part of a written emergency action plan.
Know your plan. Every person prescribed an auto-injector should have a personalised anaphylaxis action plan agreed with their allergy specialist or GP. This plan should specify which triggers to avoid, what the first signs of reaction look like for that individual, when to use the auto-injector, and exactly what steps to follow afterwards. It should be shared with school staff, carers, employers, and anyone regularly in close contact with the person.
Training: The Step That Too Many People Skip
Research consistently shows that carrying an auto-injector and knowing how to use one are not the same thing. Studies have found that significant proportions of both patients and their carers cannot correctly operate their prescribed device under simulated emergency conditions. This is not a reflection of intelligence or care — it is a reflection of the fact that training under calm conditions, with a trainer device, is what builds the muscle memory needed to act quickly under stress.
Most allergy clinics provide training at the point of prescription. Trainer devices — inert replicas of the real injector that allow practice without delivering any drug — are available and should be used regularly to maintain familiarity. First aid training courses that cover anaphylaxis and auto-injector use are available through organisations including St John Ambulance and the British Red Cross.
The mnemonic, the positioning, the 999 call, the second device — none of this is complicated in principle. What transforms knowledge into effective action in an emergency is repetition. Practise with the trainer pen. Recite the steps. Make the response automatic, so that when adrenaline is flooding someone else’s system, you are not standing still trying to remember which end is which.
A Final Note on Awareness
The allergy epidemic described elsewhere in these pages is not an abstraction. For those living with severe allergic disease, it has a concrete, daily weight: the label-checking, the restaurant conversations, the quiet calculation of risk that accompanies every meal away from home. The auto-injector is the last line of defence against a system that has been pushed past its limits.
Knowing how to use it — and how to respond in the minutes after — is not a niche piece of medical knowledge. It is the kind of information that belongs in every household, every school, every workplace. Anaphylaxis does not wait for the person present to have been trained. The more widely these steps are understood, the more lives will be saved by bystanders who happened to be in the right place and knew exactly what to do.
Sources include NHS.uk, NHS Inform (Scotland), the Medicines and Healthcare products Regulatory Agency (MHRA), the Resuscitation Council UK, GOV.UK drug safety updates, the British Society for Allergy and Clinical Immunology (BSACI), Medicines for Children, and React First anaphylaxis training resources.